Arizona Tribune - Moderna to Present at Upcoming Piper Sandler's 37th Annual Healthcare Conference on December 2, 2025

NYSE - LSE

RBGPF	0%	78.35	$
VOD	-1.31%	12.47	$
NGG	-0.66%	75.41	$
SCS	-0.56%	16.14	$
CMSC	-0.21%	23.43	$
BCC	-1.66%	73.05	$
CMSD	-0.3%	23.25	$
RELX	-0.55%	40.32	$
BCE	1.4%	23.55	$
RIO	-0.92%	73.06	$
RYCEF	-1.1%	14.49	$
JRI	0.29%	13.79	$
AZN	0.17%	90.18	$
BP	-3.91%	35.83	$
GSK	-0.33%	48.41	$
BTI	-1.81%	57.01	$

Moderna to Present at Upcoming Piper Sandler's 37th Annual Healthcare Conference on December 2, 2025

BOULEVARD 18.11.2025

CAMBRIDGE, MASSACHUSETTS / ACCESS Newswire / November 18, 2025 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conference:

Text size:

Piper Sandler's 37^th Annual Healthcare Conference, on Tuesday, December 2^nd at 11:00am ET

A live webcast of each of the presentation will be available under "Events and Presentations" in the Investors section of the Moderna website.

investors.modernatx.com.

A replay of the webcast will be archived on Moderna's website for at least 30 days following the presentation.

About Moderna

Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including one of the earliest and most effective COVID-19 vaccines.

Moderna's mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global team driven by the Moderna values and mindsets to responsibly change the future of human health, Moderna strives to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn.

Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
[email protected]

SOURCE: Moderna, Inc.

View the original press release on ACCESS Newswire

W.Stewart--AT

Featured

Witness in South Africa justice-system crimes probe shot dead

10 university students die in Peru restaurant fire

Migration and crime fears loom over Chile's presidential runoff

$French officer charged after police fracture woman's skull$